DIS
68
4
ADT
48
2
JPM
69
2
IRM
55
6
PLD
48
2
CTAS
40
6
AIZ
59
5
NI
62
2
WMB
51
3
HSY
35
3
BIIB
48
-3
UNH
36
3
VZ
39
2
AES
57
2
IFF
48
-6
BLK
64
3
KMX
42
-5
AA
72
3
EQIX
53
4
PFE
39
-12
DIS
68
4
ADT
48
2
JPM
69
2
IRM
55
6
PLD
48
2
CTAS
40
6
AIZ
59
5
NI
62
2
WMB
51
3
HSY
35
3
BIIB
48
-3
UNH
36
3
VZ
39
2
AES
57
2
IFF
48
-6
BLK
64
3
KMX
42
-5
AA
72
3
EQIX
53
4
PFE
39
-12
Financhill
Back

Palo Alto Networks, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
46

PANW
Palo Alto Networks, Inc.

Last Price:
$190.37
Seasonality Move:
8.47%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$87.93
Seasonality Move:
10.35%
Sell
46
Palo Alto Networks, Inc. (PANW) is a Sell

Is Palo Alto Networks, Inc. a Buy, Sell or Hold?

  • The current Palo Alto Networks, Inc. [PANW] share price is $190.36. The Score for PANW is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • PANW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

PANW Stock Price Chart

What is Palo Alto Networks, Inc.'s stock price today?

  • The Palo Alto Networks, Inc. share price today is $190.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PANW is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $87.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

PANW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.55 Sell
Relative Strength Index (14 RSI): 40.36 Sell
Chaikin Money Flow: -825157 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (187.1 - 207.72) Sell
Bollinger Bands (100): (183.56 - 212.02) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.53 Buy
Relative Strength Index (14 RSI): 71.11 Buy
Chaikin Money Flow: -592960 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.18 - 78.14) Buy
Bollinger Bands (100): (43.11 - 66.09) Buy

PANW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 193.96 Sell
20-day SMA: 193.34 Sell
50-day SMA: 205.46 Sell
200-day SMA: 192.13 Sell
8-day EMA: 193.08 Sell
20-day EMA: 195.62 Sell
50-day EMA: 199.89 Sell
200-day EMA: 193.85 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.75 Buy
20-day SMA: 70.43 Buy
50-day SMA: 63.87 Buy
200-day SMA: 45.05 Buy
8-day EMA: 80.77 Buy
20-day EMA: 72.92 Buy
50-day EMA: 64.9 Buy
200-day EMA: 50.57 Buy

Palo Alto Networks, Inc. Earnings Growth & PANW Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.04 per share, an increase this year of $0.49 per share, and an increase next year of $0.58 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.

Palo Alto Networks, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):